-
Information-Publications
-
Hexavalent chromium causes apoptosis and autophagy by inducing mitochondrial dysfunction and oxidative stress in broiler cardiomyocytesDetails
-
Discovery of a novel DDRs kinase inhibitor XBLJ-13 for the treatment of idiopathic pulmonary fibrosisDetails
-
LS‐106, a novel EGFR inhibitor targeting C797S, exhibits antitumor activities both in vitro and in vivoDetails
-
Borneol promotes autophagic degradation of HIF-1α and enhances chemotherapy sensitivity in malignant gliomaDetails
-
Identification of volatile biomarkers for lung cancer from different histological sources: A comprehensive studyDetails
-
Experimental Validation and Multi-omics Analysis Identified ARPC1A as a Novel Oncogene and Potential Therapeutic Target in GlioblastomaDetails
-
"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands